iXgene Inc.

iXgene Inc.

バイオテクノロジー研究

Shinjuku-ku、Tokyo51人のフォロワー

Biotech company developing genome-edited iPS cell therapies for patients with intractable diseases worldwide

概要

iXgene Inc. a biotech company based in Tokyo, is developing next-generation cell therapies based on genome-edited iPS cells. Our flagship product targets glioblastoma, one of the most challenging cancers, but our vision extends far beyond, aiming to apply this technology to various other diseases. We are building a platform that can deliver precise, scalable, and effective treatments across multiple therapeutic areas.

ウェブサイト
https://www.ixgene.inc/en/
業種
バイオテクノロジー研究
会社規模
社員 2 - 10名
本社
Shinjuku-ku、Tokyo
種類
非上場企業
創立
2020

場所

iXgene Inc.の社員

アップデート

類似するページ